Testosterone and Covid‐19: An update

YASSIN, Aksam, SABSIGH, Ridwan, AL‐ZOUBI, Raed M., ABOUMARZOUK, Omar M., ALWANI, Mustafa, NETTLESHIP, Joanne and KELLY, Daniel (2022). Testosterone and Covid‐19: An update. Reviews in Medical Virology. [Article]

Documents
30663:607639
[thumbnail of rmv.2395.pdf]
Preview
PDF
rmv.2395.pdf - Published Version
Available under License Creative Commons Attribution Non-commercial No Derivatives.

Download (805kB) | Preview
Abstract
Abstract: There is overwhelming evidence to suggest that male gender is at a higher risk of developing more severe Covid‐19 disease and thus having poorer clinical outcomes. However, the relationship between testosterone (T) and Covid‐19 remains unclear with both protective and deleterious effects on different aspects of the disease suggested. Here, we review the current epidemiological and biological evidence on the role of testosterone in the process of SARS‐CoV‐2 infection and in mediating Covid‐19 severity, its potential to serve as a biomarker for risk stratification and discuss the possibility of T supplementation as a treatment or preventative therapy for Covid‐19.
More Information
Statistics

Downloads

Downloads per month over past year

Metrics

Altmetric Badge

Dimensions Badge

Share
Add to AnyAdd to TwitterAdd to FacebookAdd to LinkedinAdd to PinterestAdd to Email

Actions (login required)

View Item View Item